Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 17;26(40):8720-8724.
doi: 10.1002/chem.202000872. Epub 2020 Jun 29.

Isoleucine Residues Determine Chiral Discrimination of Odorant-Binding Protein

Affiliations

Isoleucine Residues Determine Chiral Discrimination of Odorant-Binding Protein

Valeriia Zaremska et al. Chemistry. .

Abstract

Enzymes, receptors, and carrier proteins discriminate between enantiomers of natural and synthetic chemicals. Whereas the structural details of this phenomenon have been investigated in enzymes and receptors, much less is known for carrier proteins of hydrophobic ligands, particularly concerning the contribution of asymmetric centers in the side chains of amino acids to chirally selective binding. Working with a pig odorant-binding protein, we have found that the replacement of either one or both isoleucine residues in the binding pocket by leucines abolishes discrimination of menthol and carvone enantiomers. The results indicate that isoleucines are crucial for chiral discrimination of hydrophobic ligands, and that asymmetry in the side chain may be as important as the overall asymmetry of the protein. The results provide suggestions and guidelines for improving chiral selectivity of binding proteins and enzymes, with consequent applications in the production of enantiomerically pure drugs.

Keywords: chiral discrimination; isoleucine; mutagenesis; odorant-binding proteins; protein design.

PubMed Disclaimer

References

    1. G. Wald, Ann. N. Y. Acad. Sci. 1957, 69, 352-368.
    1. B. Nordén, J. Mol. Evol. 1978, 11, 313-332.
    1. E. J. Ariëns, Trends Pharmacol. Sci. 1993, 14, 68-75.
    1. J. Caldwell, N. Berova, O. McConnell, Chirality 2007, 19, 657-657.
    1. C. Valenzuela, C. Moreno, A. de la Cruz, Á. Macías, Á. Prieto, T. González, Chirality 2012, 24, 944-950.

LinkOut - more resources